Speech-Language Pathologists in Olney, IL Accepting Medicare

16 Speech-Language Pathologists found. Showing 1 - 16

Mrs. Joanna S Condrey, M.S.,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 410 E Mack Ave, Olney, IL 62450 Phone: 618-204-7622    Fax: 618-395-8410

Mrs. Jill Nicole Prosser, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 E Locust St, Olney, IL 62450 Phone: 618-395-7340    Fax: 618-395-6289

Samantha A Lewis Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 E Locust St, Olney, IL 62450 Phone: 618-395-7340    Fax: 618-395-6289

Mrs. Cassie D Lynch, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 E Locust St, Olney, IL 62450 Phone: 618-395-6099    Fax: 618-395-6289

Mrs. Valerie Nicole Pampe, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 E Locust St, Olney, IL 62450 Phone: 618-395-6031

Lori Rubenacker, MS-CCC/SLP-L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1099 N Van St, Olney, IL 62450 Phone: 618-395-4372

Mrs. Shari Lyn Berger, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 E Locust St, Olney, IL 62450 Phone: 618-395-6099

Mrs. Tiffany M Ochs, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 410 E Mack Ave, Olney, IL 62450 Phone: 618-553-8077

Kristen Jurgilanis, CCC/SLP-L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Holly Rd, Olney, IL 62450 Phone: 618-395-8540

Cynthia A Bateman, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 723 E Main St, Olney, IL 62450 Phone: 618-393-7732    Fax: 618-395-3123

Kaci Marie Wells Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 E Locust St, Olney, IL 62450 Phone: 618-395-6099    Fax: 618-395-6289

Lindsey Tomlin, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 410 E Mack Ave, Olney, IL 62450 Phone: 618-395-7421

Mrs. Stacey Meadows, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 E Scott St, Olney, IL 62450 Phone: 618-395-1000

Terri L Newton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 905 E Main St, Olney, IL 62450 Phone: 618-393-7732

Mrs. Rachel Leeann Yockey Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 905 E Main St, Olney, IL 62450 Phone: 618-303-4560

Heather E Tait Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Holly Rd, Olney, IL 62450 Phone: 618-395-8540

News Archive

Relationship skills to help communicate effectively during the holidays

Relationships can become strained and stressful during the holidays. Demanding schedules, financial hardships, and family issues can all get in the way of a happy holiday season. California Healthy Marriages Coalition (CHMC) would like to urge couples and individuals to embrace positive communications skills and turn the excess time spent with family and spouses in to an opportunity for deeper connection.

Scientists enticed back to Australia to tackle major health challenges

CSIRO and the Queensland Government are attracting leading overseas-based Australian scientists to return to work on major health challenges at the e-health Research Centre in Brisbane.

RIDEA joint-venture with Bickford acquires $135M for 17 assisted living, memory care communities

National Health Investors, Inc. (NYSE:NHI) announced today that its RIDEA joint-venture with Bickford Senior Living ("Bickford") has acquired 17 assisted living and memory care communities for a total purchase price of $135 million. NHI owns 85% of the joint-venture and Bickford owns 15%. The

Emergency department program reduces unnecessary admission of older patients by 33%

Roughly one third of all older patients age 65 and older visiting emergency departments nationwide are admitted to the hospital.

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors

Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that it has completed patient enrollment in a Phase 1 clinical trial evaluating the intravenous (IV) administration of JX-594, the company's lead product for the treatment of solid tumors. Jennerex expects to report the results from this trial at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in May 2010.

Read more Medical News

› Verified 5 days ago